A fundamental component of embryonic development is cell-cell communication, mediated in part by paracrine signaling pathways (ex. Shh), whose secreted ligands bind to surface receptors on nearby cells. The activity of this pathway must be exquisitely controlled, by fine-tuning the timing, spatial localization, duration of the signal - and response. Cells in the off Shh signaling mode have Patched (Ptch)-Smoothened (Smo) protein complexes at the cell membrane. Upon Shh binding to Ptch, Smo is released, allowing its accumulation on primary cilia, which triggers a signaling cascade, culminating in Gli transcriptional regulation of downstream target genes in the nucleus. The Shh morphogen diffuses from the embryonic midline in two waves. Shh is first secreted during gastrulation by the prechordal plate, in a narrow time window, and later by the ventral diencephalon. Disruption of the first wave causes holoprosencephaly (HPE, cyclopia), and suppresses optic stalk genesis. Loss of the second wave causes septo-optic dysplasia, and impairs hypothalamus, pituitary and optic nerve head formation. In the vertebrate embryo, a central eye field is specified in the anterior neural plate at the end of gastrulation, which subsequently splits to form bilateral optic vesicles by evagination from the ventral diencephalon. The growing optic vesicles become regionalized by demarcating the optic stalk (OS), neural retina (NR) and retinal pigment epithelium (RPE). Cells in the optic vesicle and stalk are primed to receive midline Hh signals, via the Patched (Ptch) receptor, but their responses are modulated by multiple mechanisms.
Another commonly used signaling system, the Notch pathway, relies on physical interactions between membrane-bound ligands and receptors on adjacent cells, severely limiting its range of action. During retinal development, this pathway orchestrates the appearance of distinct neuronal and glial cell types. Notch ligand-receptor binding induces sequential proteolytic cleavages to the receptor protein, ultimately releasing the intracellular domain (N-ICD) to form a nuclear protein complex with Rbpj, MAML, p300 and other proteins. Then the complex transcriptionally activates downstream genes, for example Hes1. Notch pathway mutations are linked to human birth defects such as Alagille Syndrome and Tetralogy of Fallot, SIgnal dysregulation can cause multiple types of cancer. We are exploring genetic and molecular intersections between the Shh and Notch signaling pathways during ocular growth, morphogenesis and patterning. We are using two spatiotemporally distinct Cre drivers (Rax-Cre and Chx10-Cre) to examine the phenotypes caused by loss- or gain-of-function of each pathway. |